{"schema_version":"secwatch.filing_event.v1","accession":"0001688757-23-000079","form_type":"8-K","ticker":"ESTA","cik":"0001688757","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.062044+00:00","generated_at":"2026-06-08T16:08:57.647385+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Establishment Labs Q3 revenue $38.5M (+0.8% YoY); net loss widens to $29.3M; cuts 2023 guidance to ~$165M","bullets":["Revenue $38.5M (+0.8% YoY); net loss $29.3M vs $18.6M; operating loss $21.0M vs $10.5M.","2023 revenue guidance lowered to ~$165M (up 2% over 2022); China approval removed from forecasts.","Cash $52.2M at Sep 30; cash burn $14.2M since Dec 31, partially offset by Apr follow-on offering.","FDA clearance of Motiva Flora SmoothSilk Tissue Expander on Oct 13; Mia Femtech 2-year data shows no capsular contracture.","Reaffirms $500M revenue target for 2026 despite near-term demand softness."],"urls":{"canonical":"https://secwatch.observer/filing/0001688757-23-000079","json":"https://secwatch.observer/filing/0001688757-23-000079.json","markdown":"https://secwatch.observer/filing/0001688757-23-000079.md","text":"https://secwatch.observer/filing/0001688757-23-000079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000079/0001688757-23-000079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000079/esta-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T16:08:57.647385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b3cae4c36603ec8294fb4fbfc84a27babe7cb16","claim":"ESTABLISHMENT LABS HOLDINGS INC. reported third quarter ended September 30, 2023 results: revenue $38.5 million. Guidance lowered.","evidence_excerpt":"and reconstruction, today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights and Outlook • Third quarter worldwide revenue of $38.5 million increased 0.8% year-over-year. • 2023 revenue guidance updated to approximately $165 million, an increase of 2% over 2022. • Third quarter loss from operations was $21.0 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000079/0001688757-23-000079-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$38.5 million"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}